PL2046312T3 - Produkty farmaceutyczne i nutraceutyki zawierające witaminę K2 - Google Patents

Produkty farmaceutyczne i nutraceutyki zawierające witaminę K2

Info

Publication number
PL2046312T3
PL2046312T3 PL07765188T PL07765188T PL2046312T3 PL 2046312 T3 PL2046312 T3 PL 2046312T3 PL 07765188 T PL07765188 T PL 07765188T PL 07765188 T PL07765188 T PL 07765188T PL 2046312 T3 PL2046312 T3 PL 2046312T3
Authority
PL
Poland
Prior art keywords
vitamin
pharmaceutical
nutraceutical products
nutraceutical
products
Prior art date
Application number
PL07765188T
Other languages
English (en)
Inventor
Cees Vermeer
Leon J. Schurgers
Jo Klaveness
Hogne Vik
Anne Bjornebye Vik
Stein Westbye
Original Assignee
Kaydence Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38820269&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2046312(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kaydence Pharma As filed Critical Kaydence Pharma As
Publication of PL2046312T3 publication Critical patent/PL2046312T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
PL07765188T 2006-07-14 2007-07-13 Produkty farmaceutyczne i nutraceutyki zawierające witaminę K2 PL2046312T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
NO20063292 2006-07-14
NO20063291 2006-07-14
NO20063988 2006-09-06
PCT/EP2007/006241 WO2008006607A2 (en) 2006-07-14 2007-07-13 Pharmaceutical and nutraceutical products comprising vitamin k2
EP07765188.3A EP2046312B1 (en) 2006-07-14 2007-07-13 Pharmaceutical and nutraceutical products comprising vitamin k2

Publications (1)

Publication Number Publication Date
PL2046312T3 true PL2046312T3 (pl) 2021-02-08

Family

ID=38820269

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07765188T PL2046312T3 (pl) 2006-07-14 2007-07-13 Produkty farmaceutyczne i nutraceutyki zawierające witaminę K2

Country Status (10)

Country Link
US (1) US20100048704A1 (pl)
EP (1) EP2046312B1 (pl)
JP (2) JP5827784B2 (pl)
AU (1) AU2007271900B2 (pl)
CA (1) CA2657748C (pl)
ES (1) ES2790590T3 (pl)
NO (1) NO343923B1 (pl)
NZ (1) NZ574882A (pl)
PL (1) PL2046312T3 (pl)
WO (1) WO2008006607A2 (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8697138B2 (en) 2007-03-28 2014-04-15 Aker Biomarine As Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders
AU2008231570C1 (en) 2007-03-28 2014-11-27 Aker Biomarine Human Ingredients As Bioeffective krill oil compositions
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
NL1034964C2 (nl) * 2008-01-28 2009-07-30 Friesland Brands Bv Werkwijze en composities voor de behandeling van botaandoeningen.
GB0817701D0 (en) * 2008-09-26 2008-11-05 Omegatri As Krill oil powder and krill oil tablets
US8372812B2 (en) 2009-02-26 2013-02-12 Aker Biomarine Asa Phospholipid and protein tablets
FR2949044B1 (fr) * 2009-08-12 2021-05-07 Expanscience Lab Composition comprenant une fraction d'insaponifiable
AU2010292439A1 (en) * 2009-09-14 2012-04-12 Nestec S.A. Nutritional compositions including exogenous vitamin K2
GB2476644B (en) * 2009-12-23 2012-11-14 Haomamedica Ltd 1,4-Dihydro-1,4-dioxonaphtalene derivatives for the treatment of osteoporosis
EP2601168A4 (en) * 2010-08-06 2013-12-04 Ampere Life Sciences Inc TREATMENT OF MITOCHONDRIAL DISEASES BY VITAMIN K
CA2815781A1 (en) * 2010-11-01 2012-05-10 Viridis Biopharma Pvt. Ltd. Dynamic balancing of autonomic nervous system through vitamin mk-7
WO2012161572A1 (en) * 2011-05-20 2012-11-29 Friesland Brands B.V. Composition comprising vitamin k2
NL2008294C2 (en) * 2011-05-20 2013-08-19 Friesland Brands Bv Food composition comprising vitamin k and saturated fat.
AU2014203179C1 (en) 2013-06-14 2017-05-04 Aker Biomarine Antarctic As Lipid extraction processes
EP2886129A1 (en) 2013-12-20 2015-06-24 VitaK B.V. Prevention and counteraction of diet-induced thrombosis risk
GB201400431D0 (en) 2014-01-10 2014-02-26 Aker Biomarine As Phospholipid compositions and their preparation
ES2937960T5 (en) 2015-02-11 2026-02-16 Aker Biomarine Human Ingredients As Lipid extraction processes
CN107580457A (zh) 2015-02-11 2018-01-12 阿克海洋生物南极股份公司 脂质组合物
US11478429B2 (en) 2015-10-09 2022-10-25 Combocap, Inc. Capsule with internal diaphragm and solid ingredients
EP3773530A4 (en) 2018-03-30 2022-03-02 Kaydence Pharma AS RAPID IMPROVEMENT OF VASCULAR DISEASES BY ADMINISTRATION OF VITAMIN K
WO2019237053A1 (en) 2018-06-08 2019-12-12 Epizon Pharma, Inc. Methods and compositions for preventing or treating tissue calcification
AU2019282421B2 (en) 2018-06-08 2025-01-09 Epizon Pharma, Inc. Methods and compositions for preventing or treating calciphylaxis
WO2021165859A1 (en) * 2020-02-19 2021-08-26 Yogesh Dound A composition comprising vitamin k2-7 in combination with vitamin k-1 in purest form
CN114748486A (zh) * 2022-03-25 2022-07-15 南京盛德生物科技研究院有限公司 一种含有维生素k2改善心血管钙化的药物组合物及其制备方法与应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1176916B (it) * 1984-10-10 1987-08-18 Elvira Pistolesi Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
JP2577584B2 (ja) * 1987-11-13 1997-02-05 雪印乳業株式会社 多価不飽和脂肪酸とビタミンａを含有する組成物の保存方法
US5180747A (en) * 1989-02-28 1993-01-19 Nisshin Flour Milling Co., Ltd. Stabilized fat-soluble vitamin compositions
JPH03254658A (ja) * 1990-03-01 1991-11-13 Binshiyoo:Kk 納豆によるスナック食品の製造法
JPH04253908A (ja) * 1990-12-28 1992-09-09 Nippon Oil & Fats Co Ltd 骨粗鬆症治療薬
JP3092180B2 (ja) * 1991-02-27 2000-09-25 日本油脂株式会社 低密度リポ蛋白受容体活性化剤
IT1274734B (it) * 1994-08-25 1997-07-24 Prospa Bv Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti
GB9713620D0 (en) 1997-06-28 1997-09-03 Boots Co Plc Composition
GB9901809D0 (en) * 1999-01-27 1999-03-17 Scarista Limited Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes
US7226916B1 (en) * 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
EP1153548B8 (en) 2000-05-12 2007-06-27 NattoPharma ASA Vitamin k2 containing food product
GB0016452D0 (en) * 2000-07-04 2000-08-23 Kilgowan Limited Vitamin K and essential fatty acids
BRPI0208103B8 (pt) * 2001-03-15 2021-05-25 Dsm Ip Assets Bv composição para a prevenção de osteoporose compreendendo uma combinação de isoflavonas e ácidos graxos poliinsaturados, seu uso, composição dietética, bem como formulação galênica que compreende a dita composição dietética
ATE554779T1 (de) * 2001-06-18 2012-05-15 Neptune Technologies & Bioressources Inc Krill zur prävention und/oder behandlung von herz-kreislauf-erkrankungen
CN1250184C (zh) * 2001-10-09 2006-04-12 桑尼研究基金会 治疗体位性低血压的非侵入性的方法及设备
JP2003169632A (ja) * 2001-12-08 2003-06-17 Sapuri:Kk 米胚芽油、卵黄油及びホスファチジルセリン含有の健康食品
JP2003313142A (ja) * 2002-02-20 2003-11-06 En Otsuka Pharmaceutical Co Ltd 栄養組成物
JP3999532B2 (ja) * 2002-02-26 2007-10-31 三菱重工業株式会社 輸送用冷凍装置
GB0210212D0 (en) * 2002-05-03 2002-06-12 Univ Southampton Effects of dietary N-3 and N-6 pufa intake on atheromatous plaque stability
GB0220182D0 (en) * 2002-08-30 2002-10-09 Cardiovascular Res Inst Maastr Organic compounds
EP1675580A1 (en) * 2003-09-26 2006-07-05 Natural ASA Natural menaquinone 7 compositions
JP2005237300A (ja) * 2004-02-26 2005-09-08 Aichi Prefecture 食品素材及びその製造方法

Also Published As

Publication number Publication date
WO2008006607A2 (en) 2008-01-17
EP2046312A2 (en) 2009-04-15
WO2008006607A3 (en) 2008-10-23
JP2014031378A (ja) 2014-02-20
JP2009544590A (ja) 2009-12-17
EP2046312B1 (en) 2020-02-19
CA2657748A1 (en) 2008-01-17
US20100048704A1 (en) 2010-02-25
CA2657748C (en) 2014-10-21
NZ574882A (en) 2012-08-31
NO343923B1 (no) 2019-07-08
AU2007271900A1 (en) 2008-01-17
ES2790590T3 (es) 2020-10-28
JP5827784B2 (ja) 2015-12-02
NO20090692L (no) 2009-04-01
AU2007271900B2 (en) 2013-05-23

Similar Documents

Publication Publication Date Title
PL2046312T3 (pl) Produkty farmaceutyczne i nutraceutyki zawierające witaminę K2
IL275854A (en) Pharmaceutical composition and its administration
IL242883B (en) Aryl-amino and heteroaryl-amino converted deoxazolines and pharmaceutical preparations containing them
IL217916A0 (en) Pharmaceutical products
GB0803072D0 (en) Solid pharmaceutical and vaccien dose
IL194546A0 (en) Arylaminopyridine derivatives and pharmaceutical compositions containing them
ZA200901464B (en) Packaging comprising pharmaceutical forms
IL214911A0 (en) Solfonylated tetrahydroazolopyrazines and their use as medicinal products
PL2399579T3 (pl) Farmaceutyczne postacie dawkowania
IL202622A (en) Purin derivatives and pharmaceuticals containing them
ZA200900423B (en) Methods and medicaments for administration of ibuprofen
IL194751A0 (en) Drugs and uses
IL193211A (en) Derivatives of Indzol-Troaril and pharmaceutical preparations containing them
EP2135074A4 (en) PHARMACEUTICAL PLATFORM TECHNOLOGY FOR THE DEVELOPMENT OF NATURAL PRODUCTS
IL197107A0 (en) Pharmaceutical compositions including vitamin d and corticosteriod
IL197877A (en) Uses of aminomethyl-4-imidazole derivatives for the preparation of medications and medications containing them
PL2173195T3 (pl) Biomasa wzbogacona w cynk, sposób jej wytwarzania oraz zawierające ją produkty probiotyczne, kosmetyczne, dietetyczne i nutraceutyczne
IL183178A (en) Pharmaceutical products containing at least three solid tablets and methods for making them
ZA201204619B (en) Pharmaceutical composition comprising vitamin d analogue and cosolventsurfactant mixture
IL197273A0 (en) Pharmaceutical and sunscreen compositions comprising caspase-14
ZA201101752B (en) A medicinal product and treatment
GB0614586D0 (en) Pharmaceutical Formulation
IL195822A0 (en) Segmented pharmaceutical dosage forms
ZA201000853B (en) Pharmaceutical product comprising yeast
PL2008655T3 (pl) Kompozycja farmaceutyczna zawierająca środek przeciwbólowy i witaminy